로딩 중…
지수 로딩 중…
Erasca, Inc.
ERAS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$13.67-2.22%
2026-06-18
Price Chart
Erasca, Inc.+876.43%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $4.25B |
| Revenue | $0.00 |
| Net Income | $-277M |
| Total Assets | $461M |
| Net Assets | $394M |
| Value | |
| P/B | 10.80x |
| FCF Yield | -2.15% |
| Profitability | |
| ROE | -70.39% |
| ROA | -60.06% |
| Financial Health | |
| Debt Ratio | 17.20% |
| Total Debt | $46M |
| FCF | $-91M |
| Cash | $47M |
| Current Ratio | 9.52x |
| Performance | |
| 1Y Return | 876.43% |
| 1M Return | 32.46% |
| From 52W High | -43.70% |
| 1Y MDD | -59.46% |
| Trading | |
| Volume | 7,435,343 shares |
| Trading Value | $104M |
| Per Share | |
| EPS | $-0.44 |
| BPS | $1.15 |